Testing effectiveness (Phase 2)Looking for participantsNCT07238712
What this trial is testing
Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor
Who this might be right for
Acute Myeloid Leukemia (AML)Chronic Myeloid LeukemiaMyelodysplastic Syndromes (MDS)+2 more
St. Petersburg State Pavlov Medical University 60